Finland's Medisize to increase production of components for Sanofi-aventis insulin pens

Medisize, a European manufacturer of medical & diagnostic devices and pharma- packaging, has announced to set up additional capacity at its Kontiolahti (Finland) plant for production of components used in Sanofi-aventis insulin injection pens. Sanofi-aventis insulin injection pens offer diabetes patients a convenient way to manage their condition. Finland-headquartered Medisize has been involved in the pen components production line for Sanofi-aventis and worked in very close cooperation with the customer for manufacturing, tooling design, moulding and automatic assembly. The capacity addition project underlines the long-term partnership between Medisize and Sanofi-aventis.
  More News  Post Your Comment
{{comment.Name}} made a post.




There are no comments to display. Be the first one to comment!


Name Required.


Email Id Required.

Email Id Not Valid.


Mobile Required.

Email ID and Mobile Number are kept private and will not be shown publicly.

Message Required.

Click to Change image  Refresh Captcha